Key references: Available immunotherapies for multiple sclerosis

  • Broadley SA, Barnett MH, Boggild M, Brew BJ, Butzkueven H, Heard R, et al. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective. Part 2: New and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association of Neurologists. J Clin Neurosci 2014;21(11):1847–56. https://www.ncbi.nlm.nih.gov/pubmed/24986155
  • Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, et al. Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis. N Engl J Med 2017;376(3):221–34. https://www.ncbi.nlm.nih.gov/pubmed/28002679